What is the equity of Dr Hoenle this year?
Dr Hoenle has equity of 95.82 M EUR this year.
Dr Hoenle Equity 2024
Dr Hoenle Equity
95.82 M EUR
Dr Hoenle Dividend yield
Ticker
HNL.DE
ISIN
DE0005157101
WKN
515710
In 2024, Dr Hoenle's equity was 95.82 M EUR, a -10.35% increase from the 106.88 M EUR equity in the previous year.
Dr Hoenle Aktienanalyse
What does Dr Hoenle do?
The Dr Hoenle AG is a traditional company specializing in the production and distribution of UV systems, industrial drying systems, adhesives, and coating systems. It was founded in 1972 by Dr. Rolf Hoenle in Gräfelfing near Munich and has an international customer base. The history of Dr Hoenle AG began in the 1960s when Dr. Hoenle recognized the importance of UV technology for the industry and intensified his research in this area. In the 1970s, the company built its first UV exposure systems and thus developed into a leading manufacturer of UV systems. Dr Hoenle AG has divided its activities into various divisions. The UV Technology and Process Engineering department specializes in the production of UV systems. The UV systems are used in various industries, such as the paint, coating, automotive, paper, and printing industries. The UV systems can be used for curing coatings, disinfecting surfaces, and drying paints and varnishes. The industrial drying systems division specializes in the design and construction of drying systems for materials. The drying systems are used, among other things, in the textile industry, packaging and label printing, and food processing. The Adhesives and Coating Systems department produces innovative adhesives and coatings for various applications. The products are used, for example, in the automotive and electronics industries, as well as in construction and furniture manufacturing. Dr Hoenle AG has a wide range of products in its portfolio. The UV systems are available in various designs and sizes and can be customized to meet the individual needs of customers. The industrial drying systems are available in various designs, such as through-feed systems or tunnel systems. The adhesive and coating-based products are characterized by their high quality and long-term stability. The business model of Dr Hoenle AG is based on the production of innovative products that are produced to the highest quality standards. The products are characterized by reliability, durability, and functionality. The company has extensive experience in the development of solutions and technologies and is therefore often chosen as a competent and reliable partner. The products are distributed internationally and customers can be found all over the world. Dr Hoenle AG has set itself the goal of constantly developing its products and technologies to meet the needs of customers. To achieve this, the company invests high amounts in research and development every year. Dr Hoenle AG also operates its own research laboratory and is constantly striving to drive forward new solutions and applications in various industries. In summary, Dr Hoenle AG is a renowned company with extensive experience in its industry. The company produces high-quality products and offers innovative solutions for a wide range of applications and industries. Thanks to research and development and the relentless search for new solutions, Dr Hoenle AG will also maintain its position as a leading company in global markets in the future. Dr Hoenle ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Dr Hoenle's Equity
Dr Hoenle's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Dr Hoenle's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Dr Hoenle's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Dr Hoenle's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Dr Hoenle’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Dr Hoenle Stock
What was the equity of Dr Hoenle compared to the previous year?
The equity of Dr Hoenle has increased/decreased by -10.35% decreased compared to the previous year.
What impact does a high equity have on investors of Dr Hoenle?
A high equity is advantageous for investors of Dr Hoenle as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Dr Hoenle?
A low equity can be a risk for investors of Dr Hoenle, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Dr Hoenle affect the company?
An increase in equity of Dr Hoenle can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Dr Hoenle affect the company?
A reduction in equity of Dr Hoenle can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Dr Hoenle?
Some factors that can affect the equity of Dr Hoenle include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Dr Hoenle so important for investors?
The equity of Dr Hoenle is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Dr Hoenle take to change the equity?
To change equity, Dr Hoenle can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Dr Hoenle pay?
Over the past 12 months, Dr Hoenle paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dr Hoenle is expected to pay a dividend of 0 EUR.
What is the dividend yield of Dr Hoenle?
The current dividend yield of Dr Hoenle is .
When does Dr Hoenle pay dividends?
Dr Hoenle pays a quarterly dividend. This is distributed in the months of April, June, April, April.
How secure is the dividend of Dr Hoenle?
Dr Hoenle paid dividends every year for the past 0 years.
What is the dividend of Dr Hoenle?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Dr Hoenle located?
Dr Hoenle is assigned to the 'Industry' sector.
Wann musste ich die Aktien von Dr Hoenle kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Dr Hoenle from 3/29/2022 amounting to 0.2 EUR, you needed to have the stock in your portfolio before the ex-date on 3/25/2022.
When did Dr Hoenle pay the last dividend?
The last dividend was paid out on 3/29/2022.
What was the dividend of Dr Hoenle in the year 2023?
In the year 2023, Dr Hoenle distributed 0.2 EUR as dividends.
In which currency does Dr Hoenle pay out the dividend?
The dividends of Dr Hoenle are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Dr Hoenle stock can be added to a savings plan with the following providers: Trade Republic and Scalable Capital
Andere Kennzahlen von Dr Hoenle
Our stock analysis for Dr Hoenle Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dr Hoenle Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
